Skip to main content
TipRanks
Go Ultimate75% OFF

GRI Bio (GRI) Stock Statistics & Valuation Metrics

369 Followers

Total Valuation

GRI Bio has a market cap or net worth of $3.06M. The enterprise value is -$7.71M.

Market Cap
$3.06M
Enterprise Value
-$7.71M

Share Statistics

GRI Bio has 2,186,115 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,186,115
Owned by Insiders
0.40%
Owned by Institutions
2.41%

Financial Efficiency

GRI Bio’s return on equity (ROE) is -1.99 and return on invested capital (ROIC) is -197.02%.

Return on Equity (ROE)
-1.99
Return on Assets (ROA)
-1.38
Return on Invested Capital (ROIC)
-197.02%
Return on Capital Employed (ROCE)
-1.99
Revenue Per Employee
0
Profits Per Employee
-2.99M
Employee Count
4
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of GRI Bio is -0.17. GRI Bio’s PEG ratio is -0.00.

PE Ratio
-0.17
PS Ratio
0.00
PB Ratio
0.36
Price to FCF
-1.07
Price to Operating Cash Flow
-1.07
PEG Ratio
-0.00

Income Statement

In the last 12 months, GRI Bio had revenue of 0 and earned -11.96M in profits. Earnings per share was -121.80.

Revenue
0
Gross Profit
-4,000
Operating Income
-11.98M
Pretax Income
-11.96M
Net Income
-11.96M
EBITDA
-11.97M
Earnings Per Share (EPS)
-121.80

Cash Flow

In the last 12 months, operating cash flow was -5.28M and capital expenditures -3,000, giving a free cash flow of -5.29M billion.

Operating Cash Flow
-5.28M
Free Cash Flow
-5.29M
Free Cash Flow per Share
-1.36

Dividends & Yields

GRI Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-94.47%
Earnings Yield
-247.97%

Stock Price Statistics

Beta
2.81
52-Week Price Change
-97.04%
50-Day Moving Average
1.76
200-Day Moving Average
2.03
Relative Strength Index (RSI)
41.03
Average Volume (3m)
219.30K

Important Dates

GRI Bio upcoming earnings date is May 20, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 19, 2026
Next Earnings Date
May 20, 2027
Ex-Dividend Date
―

Financial Position

GRI Bio as a current ratio of 3.25, with Debt / Equity ratio of 1.18%

Current Ratio
3.25
Quick Ratio
3.25
Debt to Market Cap
0.00
Net Debt to EBITDA
0.68
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, GRI Bio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

GRI Bio EV to EBITDA ratio is 0.80, with an EV/FCF ratio of 2.12.

EV to Sales
0.00
EV to EBITDA
0.80
EV to Free Cash Flow
2.12
EV to Operating Cash Flow
2.12

Balance Sheet

GRI Bio has $9.47M in cash and marketable securities with $30.00K in debt, giving a net cash position of $9.44M billion.

Cash & Marketable Securities
$9.47M
Total Debt
$30.00K
Net Cash
$9.44M
Net Cash Per Share
$4.32
Tangible Book Value Per Share
$4.03

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for GRI Bio is $27.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$27.00
Price Target Upside
1828.57% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
98.06%

Scores

Smart Score
―
AI Score
46